share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  05/02 10:48
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 05/02/2024, with an aggregate market value of $423,500. The shares to be sold were acquired through various means, including stock option exercises on 08/02/2023 and 11/01/2023, restricted stock vesting on 08/15/2023, and as founder's shares on 09/01/2016. The transactions for acquiring these shares involved payments in cash and as compensation. This planned sale follows a series of transactions over the past three months, where a total of 354,591 shares were sold for gross proceeds of $3,368,336.79. The notice for the upcoming sale was filed on the same day as the planned sale, with the sale plan having been adopted on 12/27/2023.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 05/02/2024, with an aggregate market value of $423,500. The shares to be sold were acquired through various means, including stock option exercises on 08/02/2023 and 11/01/2023, restricted stock vesting on 08/15/2023, and as founder's shares on 09/01/2016. The transactions for acquiring these shares involved payments in cash and as compensation. This planned sale follows a series of transactions over the past three months, where a total of 354,591 shares were sold for gross proceeds of $3,368,336.79. The notice for the upcoming sale was filed on the same day as the planned sale, with the sale plan having been adopted on 12/27/2023.
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定於2024年2月5日出售5萬股A類股票，總市值爲423,500美元。待出售的股票是通過各種方式收購的，包括2023年2月8日和2023年1月11日的股票期權行使，2023年8月15日的限制性股票歸屬，以及2016年1月9日作爲創始人的股票進行收購。收購這些股份的交易涉及現金支付和補償。此次計劃出售是在過去三個月進行的一系列交易之後進行的，共出售了354,591股股票，總收益爲3,368,336.79美元。即將進行的銷售的通知是在計劃銷售的同一天提交的，銷售計劃已於2023年12月27日通過。
Recursion Pharmicals, Inc.高管兼董事克里斯托弗·吉布森定於2024年2月5日出售5萬股A類股票，總市值爲423,500美元。待出售的股票是通過各種方式收購的，包括2023年2月8日和2023年1月11日的股票期權行使，2023年8月15日的限制性股票歸屬，以及2016年1月9日作爲創始人的股票進行收購。收購這些股份的交易涉及現金支付和補償。此次計劃出售是在過去三個月進行的一系列交易之後進行的，共出售了354,591股股票，總收益爲3,368,336.79美元。即將進行的銷售的通知是在計劃銷售的同一天提交的，銷售計劃已於2023年12月27日通過。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息